Page results
-
A healthcare project aimed at homeless people and delivered by UCLH has been specially commended in this year’s London Homelessness Awards.
-
Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.
-
Bed availability is a “significant” factor in determining whether or not a patient is admitted to a critical care bed after surgery, questioning whether some are getting the care they need, a new study from researchers at UCL and UCLH has found for the first time.
-
This page offers advice to patients who are feeling sick.
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Wednesday 29 January 2025.
-
Short videos on managing cancer pain, cancer-related fatigue and improving sleep
-
This page provides information for pregnant women with Inflammatory Bowel Disease.
-
At UCLH we run seasonal COVID-19 vaccination clinics from our Hospital Hub within UCH. Vaccinations are available to members of the eligible public as well as UCLH patients.
-
This information is for UCLH patients with cancer or a blood condition who are being offered a PICC (peripherally inserted central catheter).
-
Learn more about how UCLH celebrated Research Open Day this month.
File results
-
FOI/2024/0184 - IT spend/ Healthcare Information and Management Systems Society (HIMSS) EMRAM and INFRAM scores
-
FOI/2024/0190 - Scheduled appointments Did Not Attend (DNA) 2019-2023
-
FOI/2024/0192 - Net zero and decarbonisation targets
-
FOI/2024/0462 - Patient information leaflets and e-consent systems
-
FOI/2024/0198 - Nurse intake at Band 5
-
FOI/2024/0199 - Admission and discharge policies for violent assault injuries/ autism/ patient records/ inaccurate records
-
FOI/2024/0204 - Clinical insourcing for audiology and pathology
-
FOI/2024/0206 - Trusts budget allocated for cancer funding 2019/20-2023/24
-
FOI/2024/0207 - Physician Associates and prescribing/ ionising radiation
-
FOI/2024/0214 - Treatment for myeloproliferative neoplasms